TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06961747: An Open-Label, Repeated-Dose Assessment of Zilucoplan Concentration in Breast Milk of Healthy Lactating Women

Sponsor: UCB Biopharma SRL · Phase: PHASE1 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 20 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$3,883,072

Rescue Site Savings

+$2,573,664

Unlock Full NCT06961747 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06961747 Rescue Dossier →